Quarterly report · Q3
3034.TEDINET S100Q6EO
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥126.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥166.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥124.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥6.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥6.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.1bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.1bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥4.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥105.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥96.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥103.0bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥58.3bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥52.1bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥47.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥43.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥42.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥26.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥16.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥112.57 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.43 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥149.51 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.26 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.26 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.1% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥2.6bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥115.4bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥115.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥66m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.1bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥250m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥126.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥126.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥317m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥9.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥308m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥308m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥2.4bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥114.9bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥114.9bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥46m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥8.4bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥9.9bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥9.7bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥261m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥930m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥124.9bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥124.5bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥308m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥9.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 367
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 124854000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -308000000 | JPY |
| Net sales | Prior1YTDDuration | 124545000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 8413000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember | 930000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 9343000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -2422000000 | JPY |
| Operating income | Prior1YTDDuration | 6921000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 115286000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember | 10814000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 126101000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 126101000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 66000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember | 250000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 317000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -317000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 115353000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember | 11065000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 126418000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -317000000 | JPY |
| Net sales | CurrentYTDDuration | 126101000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember | 8275000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember | 1158000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 9434000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -2593000000 | JPY |
| Operating income | CurrentYTDDuration | 6841000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-02-13 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第31期第３四半期 (自 2022年10月１日 至 2022年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)クオールホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Qol Holdings Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 中村 敬 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03－6430－9060 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営管理部 部長 緒方 伸一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03－6430－9060 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理部 部長 緒方 伸一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03476 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 30340 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)クオールホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Qol Holdings Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |